RTX-1688

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRTX-1688
Drug Alias NameRTX-1688
ClassificationSmall molecules
Mechanisms of ActionHydroxyprostaglandin dehydrogenases inhibitors
TargetsHydroxyprostaglandin dehydrogenases
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRodeo Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesRodeo Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A